Literature DB >> 27307466

Reproductive Factors and Risk of Luminal, HER2-Overexpressing, and Triple-Negative Breast Cancer Among Multiethnic Women.

Lu Chen1, Christopher I Li2, Mei-Tzu C Tang2, Peggy Porter3, Deirdre A Hill4, Charles L Wiggins4, Linda S Cook4.   

Abstract

BACKGROUND: Reproductive factors are among the most well-established risk factors for breast cancer. However, their associations with different breast cancer subtypes defined by joint estrogen receptor (ER)/progesterone receptor (PR)/HER2 status remain unclear.
METHODS: We assessed relationships between reproductive factors and risks of luminal A (ER(+)/HER2(-)), luminal B (ER(+)/HER2(+)), triple-negative (TN; ER(-)/PR(-)/HER2(-)), and HER2-overexpressing (H2E; ER(-)/HER2(+)) breast cancers in a population-based case-case study consisting of 2,710 women ages 20-69 years diagnosed between 2004 and 2012. ORs and 95% confidence intervals (CI) were estimated with luminal A cases serving as the reference group using polytomous logistic regression.
RESULTS: Earlier age at first full-term pregnancy and age at menopause were positively associated with odds of TN breast cancer (Ptrend: 0.003 and 0.024, respectively). Parity was associated with a 43% (95% CI, 1.08-1.89) elevated odds of H2E breast cancer, and women who had ≥3 full-term pregnancies had a 63% (95% CI, 1.16-2.29, Ptrend = 0.013) increased odds of this subtype compared with nulliparous women. Breast feeding for ≥36 months was associated with a 49% (OR 0.51; 95% CI, 0.27-0.99) lower odds of TN breast cancer.
CONCLUSION: Our results suggest that reproductive factors contribute differently to risks of the major molecular subtypes of breast cancer. IMPACT: African American and Hispanic women have higher incidence rates of the more aggressive TN and H2E breast cancers and their younger average age at first pregnancy, higher parity, and less frequent breast feeding could in part contribute to this disparity. Cancer Epidemiol Biomarkers Prev; 25(9); 1297-304. ©2016 AACR. ©2016 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27307466      PMCID: PMC5010505          DOI: 10.1158/1055-9965.EPI-15-1104

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  34 in total

1.  Timing of menarche and first full-term birth in relation to breast cancer risk.

Authors:  Christopher I Li; Kathleen E Malone; Janet R Daling; John D Potter; Leslie Bernstein; Polly A Marchbanks; Brian L Strom; Michael S Simon; Michael F Press; Giske Ursin; Ronald T Burkman; Suzanne G Folger; Sandra Norman; Jill A McDonald; Robert Spirtas
Journal:  Am J Epidemiol       Date:  2007-10-26       Impact factor: 4.897

2.  Reproductive history and oral contraceptive use in relation to risk of triple-negative breast cancer.

Authors:  Amanda I Phipps; Rowan T Chlebowski; Ross Prentice; Anne McTiernan; Jean Wactawski-Wende; Lewis H Kuller; Lucile L Adams-Campbell; Dorothy Lane; Marcia L Stefanick; Mara Vitolins; Geoffrey C Kabat; Thomas E Rohan; Christopher I Li
Journal:  J Natl Cancer Inst       Date:  2011-02-23       Impact factor: 13.506

3.  Risk factors by molecular subtypes of breast cancer across a population-based study of women 56 years or younger.

Authors:  Mia M Gaudet; Michael F Press; Robert W Haile; Charles F Lynch; Sally L Glaser; Joellen Schildkraut; Marilie D Gammon; W Douglas Thompson; Jonine L Bernstein
Journal:  Breast Cancer Res Treat       Date:  2011-06-11       Impact factor: 4.872

Review 4.  Reproductive factors and breast cancer.

Authors:  J L Kelsey; M D Gammon; E M John
Journal:  Epidemiol Rev       Date:  1993       Impact factor: 6.222

5.  Reproductive factors, heterogeneity, and breast tumor subtypes in women of mexican descent.

Authors:  Maria Elena Martinez; Betsy C Wertheim; Loki Natarajan; Richard Schwab; Melissa Bondy; Adrian Daneri-Navarro; Maria Mercedes Meza-Montenegro; Luis Enrique Gutierrez-Millan; Abenaa Brewster; Ian K Komenaka; Patricia A Thompson
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-08-15       Impact factor: 4.254

6.  Molecular portraits of human breast tumours.

Authors:  C M Perou; T Sørlie; M B Eisen; M van de Rijn; S S Jeffrey; C A Rees; J R Pollack; D T Ross; H Johnsen; L A Akslen; O Fluge; A Pergamenschikov; C Williams; S X Zhu; P E Lønning; A L Børresen-Dale; P O Brown; D Botstein
Journal:  Nature       Date:  2000-08-17       Impact factor: 49.962

7.  Reproductive and hormonal risk factors for postmenopausal luminal, HER-2-overexpressing, and triple-negative breast cancer.

Authors:  Amanda I Phipps; Kathleen E Malone; Peggy L Porter; Janet R Daling; Christopher I Li
Journal:  Cancer       Date:  2008-10-01       Impact factor: 6.860

8.  Parity and breastfeeding among African-American women: differential effects on breast cancer risk by estrogen receptor status in the Women's Circle of Health Study.

Authors:  Christine B Ambrosone; Gary Zirpoli; Melanie Ruszczyk; Jyoti Shankar; Chi-Chen Hong; Demetra McIlwain; Michelle Roberts; Song Yao; Susan E McCann; Gregory Ciupak; Helena Hwang; Thaer Khoury; Lina Jandorf; Dana H Bovbjerg; Karen Pawlish; Elisa V Bandera
Journal:  Cancer Causes Control       Date:  2013-11-19       Impact factor: 2.506

9.  Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50302 women with breast cancer and 96973 women without the disease.

Authors: 
Journal:  Lancet       Date:  2002-07-20       Impact factor: 79.321

10.  Progress in increasing breastfeeding and reducing racial/ethnic differences - United States, 2000-2008 births.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2013-02-08       Impact factor: 17.586

View more
  16 in total

1.  Relationship between Diabetes and Diabetes Medications and Risk of Different Molecular Subtypes of Breast Cancer.

Authors:  Hongjie Chen; Linda S Cook; Mei-Tzu C Tang; Deirdre A Hill; Charles L Wiggins; Christopher I Li
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-08-08       Impact factor: 4.254

2.  Recent Use of Oral Contraceptives and Risk of Luminal B, Triple-Negative, and HER2-Overexpressing Breast Cancer.

Authors:  Nicole C Lorona; Linda S Cook; Mei-Tzu C Tang; Deirdre A Hill; Charles L Wiggins; Christopher I Li
Journal:  Horm Cancer       Date:  2019-04-15       Impact factor: 3.869

3.  Racial/ethnic differences in postmenopausal breast cancer risk by hormone receptor status: The multiethnic cohort study.

Authors:  Danja Sarink; Kami K White; Lenora W M Loo; Anna H Wu; Lynne R Wilkens; Loïc Le Marchand; Song-Yi Park; V Wendy Setiawan; Melissa A Merritt
Journal:  Int J Cancer       Date:  2021-09-16       Impact factor: 7.396

4.  Reproductive history differs by molecular subtypes of breast cancer among women aged ≤ 50 years in Scotland diagnosed 2009-2016: a cross-sectional study.

Authors:  Anushri Chitkara; Ines Mesa-Eguiagaray; Sarah H Wild; Peter S Hall; David A Cameron; Andrew H Sims; Jonine D Figueroa
Journal:  Breast Cancer Res Treat       Date:  2022-09-18       Impact factor: 4.624

5.  Outcomes of ovarian stimulation and fertility preservation in breast cancer patients with different hormonal receptor profiles.

Authors:  Jacques Balayla; Togas Tulandi; William Buckett; Hananel Holzer; Naama Steiner; Guy Shrem; Alexander Volodarsky-Perel
Journal:  J Assist Reprod Genet       Date:  2020-03-06       Impact factor: 3.412

Review 6.  Relationships between Breast Feeding and Breast Cancer Subtypes: Lessons Learned from Studies in Humans and in Mice.

Authors:  Christine B Ambrosone; Michael J Higgins
Journal:  Cancer Res       Date:  2020-08-14       Impact factor: 12.701

7.  Breast cancer in Asian Americans in California, 1988-2013: increasing incidence trends and recent data on breast cancer subtypes.

Authors:  Scarlett Lin Gomez; Julie Von Behren; Meg McKinley; Christina A Clarke; Salma Shariff-Marco; Iona Cheng; Peggy Reynolds; Sally L Glaser
Journal:  Breast Cancer Res Treat       Date:  2017-04-01       Impact factor: 4.624

8.  Antihypertensive medications and risks of recurrence and mortality in luminal, triple-negative, and HER2-overexpressing breast cancer.

Authors:  Nicole C Lorona; Linda S Cook; Mei-Tzu C Tang; Deirdre A Hill; Charles L Wiggins; Christopher I Li
Journal:  Cancer Causes Control       Date:  2021-08-04       Impact factor: 2.506

9.  Epidemiology of Basal-like and Luminal Breast Cancers among Black Women in the AMBER Consortium.

Authors:  Halei C Benefield; Gary R Zirpoli; Emma H Allott; Yue Shan; Amber N Hurson; Angela R Omilian; Thaer Khoury; Chi-Chen Hong; Andrew F Olshan; Traci N Bethea; Elisa V Bandera; Julie R Palmer; Christine B Ambrosone; Melissa A Troester
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-10-23       Impact factor: 4.254

10.  Breast cancer risk factors in relation to molecular subtypes in breast cancer patients from Kenya.

Authors:  Dhirendra Govender; Xiaohong R Yang; Shahin Sayed; Shaoqi Fan; Zahir Moloo; Ronald Wasike; Peter Bird; Mansoor Saleh; Asim Jamal Shaikh; Jonine D Figueroa; Richard Naidoo; Francis W Makokha; Kevin Gardner; Raymond Oigara; Faith Wambui Njoroge; Pumza Magangane; Miriam Mutebi; Rajendra Chauhan; Sitna Mwanzi
Journal:  Breast Cancer Res       Date:  2021-06-26       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.